Related Experiment Video
Updated: Jun 21, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
Published on: January 1, 2016
[Biofilm caused by fungi--structure, quorum sensing, morphogenetic changes, resistance to drugs]
Magdalena Nowak1, Piotr Kurnatowski
1Katedra Biologii i Genetyki Medycznej, Uniwersytet Medyczny, Plac J. Hallera 1, 90-647 Łódź.
Abstract:
Formation of fungal biofilms in patients with implanted biomedical prosthesis constitutes very serious clinical problems. The biofilm can lead to dysfunction of implanted material and can be a reservoir for chronic and systemic infections. Numerous investigations demonstrated differences in quantity and structure of biofilms that had been formed by various species of fungi belonged to Candida genus. Stages of biofilm formations had been examined carefully in in vitro conditions. Biofilm formation begin with adhesion of fungi to the surface, microcolonies are formed subsequently. At the end of the process, extracellular material is excreted, and its formula, that is various in different fungi Candida species, contribute to its resistance to antifungal drugs. Farnesol and tyrosol are two quorum-sensing molecules. They are acting inversely, regulating formation of "germ tubes" and influencing morphogenetic conversion between yeast and filamentous forms, which plays a very important role in pathogenicity and formation of biofilm. Drug resistance of fungi from Candida has been shown to create a very important clinical problem. Many experiments in vitro confirm significantly lower activity of antifungal drugs toward Candida biofilm than toward Candida, in the form of planctonic cells. Surprisingly, some non-steroidal anti-inflammatory drugs can inhibit biofilm formation.
Insights
Candida fungal biofilms on medical implants cause serious infections and are resistant to antifungal drugs. Some anti-inflammatory drugs may inhibit biofilm formation, offering potential new treatment avenues.
Area of Science:
- Medical Mycology
- Biomedical Engineering
- Infectious Diseases
Background:
- Fungal biofilms on biomedical prosthesis present significant clinical challenges, leading to material dysfunction and persistent infections.
- Candida species exhibit varying biofilm structures and quantities, impacting treatment efficacy.
- Biofilm formation involves fungal adhesion, microcolony development, and extracellular matrix production, contributing to drug resistance.
Purpose of the Study:
- To investigate the characteristics of fungal biofilm formation in Candida species.
- To understand the role of quorum-sensing molecules (farnesol and tyrosol) in biofilm development and pathogenicity.
- To explore potential strategies for inhibiting biofilm formation and overcoming antifungal drug resistance.
Main Methods:
- In vitro examination of Candida biofilm formation stages.
- Analysis of extracellular matrix composition and its role in resistance.
- Investigation of quorum-sensing molecule effects on fungal morphology and biofilm development.
- In vitro testing of antifungal drug activity against planktonic cells versus biofilms.
- Screening of non-steroidal anti-inflammatory drugs for biofilm inhibition.
Main Results:
- Biofilm formation progresses through distinct stages: adhesion, microcolony formation, and matrix excretion.
- Quorum-sensing molecules farnesol and tyrosol inversely regulate morphogenetic transitions crucial for pathogenicity.
- Candida biofilms demonstrate significantly higher resistance to antifungal drugs compared to planktonic cells.
- Certain non-steroidal anti-inflammatory drugs exhibit inhibitory effects on Candida biofilm formation.
Conclusions:
- Fungal biofilms on medical implants are a major clinical concern due to drug resistance and infection potential.
- Understanding biofilm development and quorum sensing is key to developing novel therapeutic strategies.
- Non-steroidal anti-inflammatory drugs represent a promising, unexplored avenue for combating Candida biofilm infections.
Related Concept Videos
Biofilms
Gene Regulation in Microbial Communities: Quorum Sensing
Development of Antibiotic Resistance
Bacterial Signaling
Antifungal Agents
Biodeterioration

